Search - tctmd.com

Displaying 81 - 100 of 178

Sort: Relevancy | Date

News Daily News

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Michael O'Riordan

June 22, 2017

News Features

Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions?

Todd Neale

June 21, 2017

News Daily News

Study Suggests VKA Monotherapy Sufficient in Patients With A-fib but No CAD

Yael L. Maxwell

June 20, 2017

News Conference News TVT 2017

Valve Leaflet Thrombosis: Treat It or Leave It Be?

Shelley Wood

June 19, 2017

News Industry News

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

June 16, 2017

News Industry News

Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair

June 16, 2017

News Conference News TVT 2017

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Shelley Wood

June 15, 2017

Presentation TVT 2017

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Presenter: Mark Reisman, Gregg W. Stone, Robert O. Bonow

June 15, 2017

News Daily News

Photosynthetic Bacteria May Aid in Repair of Myocardial Ischemia

L.A. McKeown

June 14, 2017

News Daily News

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

Michael O'Riordan

June 14, 2017

News Daily News

Use of DAPT Score Following PCI Validated in PRODIGY Study

Yael L. Maxwell

June 12, 2017

News Daily News

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

L.A. McKeown

June 12, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Industry News

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

June 08, 2017

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Michael O'Riordan

June 06, 2017

News Daily News

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Michael O'Riordan

June 05, 2017

News Features EuroPCR 2017

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Yael L. Maxwell

June 01, 2017

News Daily News

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

L.A. McKeown

May 31, 2017

News Daily News

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Michael O'Riordan

May 30, 2017

News Daily News

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

L.A. McKeown

May 23, 2017

Advertisement

One in 10 TAVR Patients Treated Off-Label: TVT Registry

Catheter Kerfuffle: How Concerning Is Off-Label Use in Stroke Interventions?

Study Suggests VKA Monotherapy Sufficient in Patients With A-fib but No CAD

Valve Leaflet Thrombosis: Treat It or Leave It Be?

4C Medical's Novel Mitral Regurgitation Therapy Highlighted at TVT Innovation Forum

Mitralign announces enrollment of first European subject in Transcatheter Tricuspid Repair Study enrolled in SCOUT II Study with Trialign™ System for Transcatheter Tricuspid Repair

Mitral Valve Repair Technologies Inch Forward, but Question of Combination Therapy Looms

Are the Guidelines Keeping Pace With Evidence Generation and Clinical Practice? Responding to a Decade of Rapidly Changing Transcatheter Valve Therapies

Photosynthetic Bacteria May Aid in Repair of Myocardial Ischemia

Aspirin Use by Elderly Patients After Vascular Events Linked to More Bleeding, Especially GI Bleeds

Use of DAPT Score Following PCI Validated in PRODIGY Study

Traditional Chinese Medicine May Aid in Prevention of Cardiovascular Disease

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

4C Medical's Mitral Regurgitation Therapy to be Featured in 2017 TVT Innovation Forum

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Debating the ARB/MI Paradox: Is It Real, or Is the Story Incomplete?

Seven Next-Generation Bioresorbable Scaffolds Show Promise but Face Major Hurdles

Beta-Blockers Questioned Anew in Post-MI Patients Without Heart Failure

Post-MI High-Intensity Statin Use Has Doubled in Recent Years

Triple Therapy Not Being Widely Used in A-fib Patients Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content